Article
Recent progress of prognostic biomarkers and risk scoring systems in chronic lymphocytic leukemia
7 Sept 2020
Abstract excerpt
Chronic lymphocytic leukemia (CLL) is the most prevalent adult leukemia with high heterogeneity in the western world. Thus, investigators identified a number of prognostic biomarkers and scoring systems to guide treatment decisions and validated them in the context of immunochemotherapy. A better understanding of prognostic biomarkers, including serum markers, flow cytometry outcomes, IGHV mutation status,...
Topics
Join the communities discussing this publication.